What Have We Learned From the Typhoid Fever Surveillance in Africa Program?

A Multicountry Molecular Analysis ofSalmonella entericaSerovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa

(2016) Hassan M. Al-Emran et al.   CLINICAL INFECTIOUS DISEASES

Variations of InvasiveSalmonellaInfections by Population Size in Asante Akim North Municipal, Ghana

(2016) Ligia M. Cruz Espinoza et al.   CLINICAL INFECTIOUS DISEASES

Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events

(2015) Vanessa K Wong et al.   NATURE GENETICS

A return to the pre-antimicrobial era?

(2015) S. Baker   SCIENCE

Typhoid fever vaccination strategies

(2015) Kashmira A. Date et al.   VACCINE

Diagnostics for invasive Salmonella infections: Current challenges and future directions

(2015) Jason R. Andrews et al.   VACCINE

Rapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre, Malawi

(2015) Nicholas A. Feasey et al.   PLoS Neglected Tropical Diseases

Development of Vi conjugate – a new generation of typhoid vaccine

(2013) Shousun Chen Szu   Expert Review of Vaccines

Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites

(2011) Karen Keddy et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The Influence of Reduced Susceptibility to Fluoroquinolones in Salmonella enterica Serovar Typhi on the Clinical Response to Ofloxacin Therapy

(2011) Christopher M. Parry et al.   PLoS Neglected Tropical Diseases

Typhoid in Kenya Is Associated with a Dominant Multidrug-Resistant Salmonella enterica Serovar Typhi Haplotype That Is Also Widespread in Southeast Asia

(2010) S. Kariuki et al.   JOURNAL OF CLINICAL MICROBIOLOGY

a study of typhoid fever in five Asian countries: disease burden and implications for controls

(2008) R Leon Ochiai   BULLETIN OF THE WORLD HEALTH ORGANIZATION